To view this email as a web page, click here.

Industry Updates
AAD offers MIPS guidance
The American Academy of Dermatology (AAD) is assisting with the Merit-based Incentive Payment System (MIPS) by offering a series of tools that guide users based on customized input.
Learn more.
ADVERTISEMENT
 
Kyocera develops image recognition technology for skin disease identification
Kyocera Communication Systems, a subsidiary of Kyocera, is teaming with the University of Tsukuba to created artificial intelligence (AI)-based technology that could identify skin cancers and other skin diseases.
Learn more.
ADVERTISEMENT
 
Digital pill caps, financial incentives fail med adherence
Neither smart technology like digital pill caps, nor financial incentives, significantly improved patients' medication adherence, a study shows.
Learn more.
 
In case you missed it
 
Propranolol equal to steroids in infantile hemangioma treatment
Prednisolone was the first-line therapy for hemangiomas for many years before propranolol was recognized as the treatment of choice in infantile hemangiomas. Both modalities have a 90% response rate.
Learn more.
 
JOB OPPORTUNITIES
 
 
ADVERTISEMENT
Eczema Resource Center
Dermatology Times brings you the latest on clinical studies, successful treatments and more — all in one place. Explore it now. »
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.